Strict Need to Void After Same-day Discharge, Non-urogynecologic, Minimally Invasive Hysterectomy

NCT ID: NCT05108506

Last Updated: 2024-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

205 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-05

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients who are undergoing non-urogynecologic, minimally invasive (laparoscopic, robotic) hysterectomy who are discharged the day of surgery will be randomized to a strict need to void versus no need to void prior to discharge.

To determine if a strict versus liberal voiding trial following the aforementioned surgery in same day discharge patients increases rates of post-operative urinary retention, urinary tract infection (UTI), or re-presentation and if there is a difference in Post-Anesthesia Care Unit (PACU) time and costs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Retention Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No strict need to void following surgery before discharge

Participants randomized to this arm will have no strict need to void following surgery before they are discharged.

Group Type EXPERIMENTAL

No Strict need to void following surgery

Intervention Type BEHAVIORAL

Certain patient will be randomized without a strict need to void prior to discharge following surgery.

Strict need to void following surgery before discharge

Participants randomized to this arm will have a strict need to void following surgery before they are discharged.

Group Type PLACEBO_COMPARATOR

Strict need to void following surgery

Intervention Type BEHAVIORAL

Certain patient will be randomized with a strict need to void prior to discharge following surgery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No Strict need to void following surgery

Certain patient will be randomized without a strict need to void prior to discharge following surgery.

Intervention Type BEHAVIORAL

Strict need to void following surgery

Certain patient will be randomized with a strict need to void prior to discharge following surgery.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women 18+ undergoing minimally invasive benign, non-urogynecologic hysterectomy
* English speaking

Exclusion Criteria

* At the surgeons discretion based on amount of bladder dissection the patient can be removed from the study at the conclusion of surgery
* Any patient with a history of prior urologic procedures
* Patients with any baseline known urinary disease
* Any bladder injury at the time of surgery
* Any combined cases with other surgical services
* Patients undergoing surgery for prolapse or incontinence symptoms
* Patients who are ultimately not discharged the same day and remain in house overnight
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Johns Hopkins University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kristin Patzkowsky

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Johns Hopkins Hospital

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB00307084

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ToT and Estrogen in Postmenopausal Females
NCT03295487 COMPLETED PHASE2/PHASE3